India wellness industry outlook 2016 robust growth in alternativeRose088
The document provides information on a report titled "India Wellness Industry Outlook 2016 – Robust Growth in Alternative Therapy and Nutraceuticals Market". The 123-page report can be purchased for $900 in PDF format, $1200 in hard copy format, or $1650 for an enterprise license. It provides an analysis of the Indian wellness industry market size and segmentation, including categories like fitness, spa services, alternative therapies, cosmetics, and nutraceuticals. The wellness industry in India grew by 16.9% in 2011, particularly among urban residents aged 25-49. The report also covers industry trends, projections, and the market for specific segments like fitness and slimming.
India waste management and recycling market outlook to 2016Rose088
The document summarizes a report on the India Waste Management and Recycling Market Outlook from 2006-2016. The 110-page report provides an analysis of the waste industry in India, focusing on municipal solid waste, industrial hazardous waste, e-waste, and bio medical waste. It details the market size and segmentation of the waste management sector in India. Key topics covered include market sizes and projections, regulations, trends, and the competitive landscape of major players. The report analyzes factors influencing industry growth and provides future projections for waste industry segments in India.
The document discusses a report on the pipeline of treatments for Hereditary Angioedema (HAE), including 82 pages on products in development from discovery to registration, with details on companies and universities involved, 20% discounts on reports over $1000, and contact information for sample reports or questions.
The document summarizes a report on the global pipeline of treatments for congestive heart failure (CHF) in the second half of 2012. The 290-page report provides an overview of CHF and treatments currently in development, including those in late stages of testing. It profiles key companies and universities researching new CHF therapies and analyzes products at different stages of development. The report aims to help identify emerging treatments and players to inform strategic decision-making around mergers, acquisitions and competitive strategies. It is available for purchase at prices ranging from $2000 to $6000 depending on the license. Contact information is provided to request a sample or related reports on other drug pipelines.
This document summarizes a 106-page report on the pipeline of therapeutics under development for acute renal failure (ARF)/acute kidney injury. The report provides an overview of the therapeutic pipeline as of the second half of 2012, including details on late-stage, mid-clinical stage, early clinical stage, and pre-clinical products. It reviews key players and universities involved in developing treatments for ARF/acute kidney injury and allows identification of emerging companies. The report can be purchased for various license fees or a sample may be requested.
Downstream processing in biopharmaceuticals adoptionRose088
This document summarizes a report from GBI Research about downstream processing in biopharmaceuticals. It discusses the adoption of disposable technologies at larger economies of scale to optimize production efficiency and cost-effectiveness. The report provides an overview of the biopharmaceutical and contract manufacturing industries as well as the downstream processing and reagent markets. It also includes market data, forecasts, profiles of key players, and an analysis of drivers and restraints. The report aims to help readers develop market strategies and understand factors shaping the industries.
This document summarizes a market research report on the pipeline of therapies for amyloidosis. The report provides an overview of therapeutic candidates in development for amyloidosis, including their current stage of development. It analyzes pipeline products by company and university, and profiles major companies involved in developing treatments for this condition, such as GlaxoSmithKline, Isis Pharmaceuticals, and Alnylam Pharmaceuticals. Sample pages of the report can be requested by email for review.
This document summarizes a market research report from Global Markets Direct about Incyte Corporation's product pipeline as of 2012. It provides an overview of Incyte's research areas and pipeline of drug candidates, including those in late-stage development and clinical trials. Key information is given about Incyte's business and locations. The full report contains additional details on pipeline candidates like mechanisms of action, development progress updates, and discontinued projects. It also includes tables, figures and references to related reports available from the publisher.
India wellness industry outlook 2016 robust growth in alternativeRose088
The document provides information on a report titled "India Wellness Industry Outlook 2016 – Robust Growth in Alternative Therapy and Nutraceuticals Market". The 123-page report can be purchased for $900 in PDF format, $1200 in hard copy format, or $1650 for an enterprise license. It provides an analysis of the Indian wellness industry market size and segmentation, including categories like fitness, spa services, alternative therapies, cosmetics, and nutraceuticals. The wellness industry in India grew by 16.9% in 2011, particularly among urban residents aged 25-49. The report also covers industry trends, projections, and the market for specific segments like fitness and slimming.
India waste management and recycling market outlook to 2016Rose088
The document summarizes a report on the India Waste Management and Recycling Market Outlook from 2006-2016. The 110-page report provides an analysis of the waste industry in India, focusing on municipal solid waste, industrial hazardous waste, e-waste, and bio medical waste. It details the market size and segmentation of the waste management sector in India. Key topics covered include market sizes and projections, regulations, trends, and the competitive landscape of major players. The report analyzes factors influencing industry growth and provides future projections for waste industry segments in India.
The document discusses a report on the pipeline of treatments for Hereditary Angioedema (HAE), including 82 pages on products in development from discovery to registration, with details on companies and universities involved, 20% discounts on reports over $1000, and contact information for sample reports or questions.
The document summarizes a report on the global pipeline of treatments for congestive heart failure (CHF) in the second half of 2012. The 290-page report provides an overview of CHF and treatments currently in development, including those in late stages of testing. It profiles key companies and universities researching new CHF therapies and analyzes products at different stages of development. The report aims to help identify emerging treatments and players to inform strategic decision-making around mergers, acquisitions and competitive strategies. It is available for purchase at prices ranging from $2000 to $6000 depending on the license. Contact information is provided to request a sample or related reports on other drug pipelines.
This document summarizes a 106-page report on the pipeline of therapeutics under development for acute renal failure (ARF)/acute kidney injury. The report provides an overview of the therapeutic pipeline as of the second half of 2012, including details on late-stage, mid-clinical stage, early clinical stage, and pre-clinical products. It reviews key players and universities involved in developing treatments for ARF/acute kidney injury and allows identification of emerging companies. The report can be purchased for various license fees or a sample may be requested.
Downstream processing in biopharmaceuticals adoptionRose088
This document summarizes a report from GBI Research about downstream processing in biopharmaceuticals. It discusses the adoption of disposable technologies at larger economies of scale to optimize production efficiency and cost-effectiveness. The report provides an overview of the biopharmaceutical and contract manufacturing industries as well as the downstream processing and reagent markets. It also includes market data, forecasts, profiles of key players, and an analysis of drivers and restraints. The report aims to help readers develop market strategies and understand factors shaping the industries.
This document summarizes a market research report on the pipeline of therapies for amyloidosis. The report provides an overview of therapeutic candidates in development for amyloidosis, including their current stage of development. It analyzes pipeline products by company and university, and profiles major companies involved in developing treatments for this condition, such as GlaxoSmithKline, Isis Pharmaceuticals, and Alnylam Pharmaceuticals. Sample pages of the report can be requested by email for review.
This document summarizes a market research report from Global Markets Direct about Incyte Corporation's product pipeline as of 2012. It provides an overview of Incyte's research areas and pipeline of drug candidates, including those in late-stage development and clinical trials. Key information is given about Incyte's business and locations. The full report contains additional details on pipeline candidates like mechanisms of action, development progress updates, and discontinued projects. It also includes tables, figures and references to related reports available from the publisher.
The document summarizes a market research report on the Chinese markets for industrial lubricants. It examines China's economic trends, industry development, supply and demand for industrial lubricants in China. The report provides historical data from 2001 to 2011 and forecasts through 2016 and 2021. It profiles major lubricant producers in China and analyzes the industrial lubricants industry capacity, market share, technology development and major end-users. The full report is available for 50% off at $2000 and contains sections on business environment, industry assessments, and production and demand for various industrial lubricants.
This document summarizes a book about national security in Mumbai. It includes 18 chapters covering various sectors like transport, power, telecom, and others. It discusses security requirements and challenges for each sector. The book aims to assess the implications of security technologies and develop an effective system to address emerging threats. It also includes security requirements for Indian states, union territories, and some other countries.
This document summarizes a market research report on the product pipeline of Zydus Cadila Healthcare Limited. The report provides details on Zydus Cadila's research areas and developmental pipeline, including current projects in various stages of development across different therapy areas. It also lists several of Zydus Cadila's pipeline candidates, including their descriptions and development progress. Contact information is provided for requesting a sample of the full market research report.
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
The document summarizes a market research report on ZIOPHARM Oncology, Inc.'s product pipeline as of 2012. It provides an overview of ZIOPHARM's research areas and developmental pipeline, including projects in various stages of development across different therapy areas. The report also includes snapshots of key pipeline candidates such as Ad-IL-12 and DC-IL-12, along with their descriptions, mechanisms of action, and research progress. Tables of contents and figures from the full report are listed as well.
Topo target a s – product pipeline review – 2012Rose088
The document summarizes a market research report from Global Markets Direct about the product pipeline of TopoTarget A/S, a pharmaceutical company. The report provides details on TopoTarget's current developmental pipeline, including projects in clinical trials and pre-clinical research across various therapy areas. It also profiles several of TopoTarget's key pipeline drugs and combination treatment modalities in development, including their descriptions, mechanisms of action, and research progress. Contact information is provided to request a sample of the full report or for questions.
Macro genics, inc. – product pipeline review – 2012Rose088
This document summarizes a market research report about MacroGenics, Inc.'s product pipeline as of 2012. It provides an overview of MacroGenics' research areas, pipeline of products in development across various therapy areas and stages of the drug development process. It also includes brief profiles of some of MacroGenics' key pipeline products in development, such as DART for autoimmune disorders, DART mAbs, and monoclonal antibodies. The full report contains additional details on MacroGenics' pipeline like lists of tables and figures as well as related reports that can be purchased.
Ym bio sciences inc. – product pipeline review – 2012Rose088
This document summarizes a market research report on YM BioSciences Inc.'s product pipeline as of 2012. It provides an overview of YM BioSciences' business and focus on key therapeutic areas. The report also details YM's pipeline of candidates in various stages of clinical development, including Phase III, Phase II and Phase I trials, as well as combination treatment modalities. It profiles several of YM's lead pipeline candidates and outlines their mechanisms of action and development progress. Contact information is provided to request a sample of the full report or for additional related pharmaceutical reports.
The document announces the availability of a market research report on the Astrocytoma therapeutic pipeline from Global Markets Direct. The report provides an overview and details on drug candidates in development for Astrocytoma, including those from companies and universities. It covers products from discovery to registration stages and key players involved. Sample pages of the report can be requested by email.
Ipsen inc. – product pipeline review – 2012Rose088
This document summarizes a market research report on Ipsen Inc.'s product pipeline in 2012. The report provides an overview of Ipsen's research areas and pipeline of drugs in development, including those in Phase III clinical trials. It also lists Ipsen's locations and subsidiaries. The document encourages requesting a sample of the full market research report or searching for similar reports on pharmaceutical pipelines and healthcare topics through the Aarkstore website.
This document summarizes a market research report on MethylGene Inc's product pipeline as of 2012. The report provides details on MethylGene's research areas and pipeline of drug candidates at various stages of clinical trials. It describes several of MethylGene's lead drug candidates, including their mechanisms of action and development progress. Tables of contents and figures are included listing the report's contents. Contact information is provided to request a sample or purchase the full report.
This document summarizes a market research report on MerLion Pharmaceuticals Pte Ltd's product pipeline as of 2012. The report provides an overview of MerLion's research areas and developmental pipeline, including both current and discontinued/dormant projects. It describes the various stages of drug development for molecules across MerLion's portfolio in therapeutic areas such as anti-virulence, antibiotics, and anti-fungals. Tables and figures in the report provide additional details on MerLion's clinical and early-stage pipeline products. Contact information is provided for inquiries about purchasing the full report.
This document summarizes a market research report on Glenmark Pharmaceuticals Ltd's product pipeline as of 2012. The report provides details on Glenmark's research areas and pipeline of drug candidates at various stages of development, including 4 drugs in late-stage Phase III trials and several others in early-stage pre-clinical testing. Tables of contents and figures are included listing the pipeline drugs and studies. Contact information is provided to request a sample or related reports on pharmaceutical company pipelines and products.
This document summarizes a market research report from Global Markets Direct about Geron Corporation's product pipeline as of 2012. The report provides an overview of Geron's research areas and pipeline of drug candidates, including those in clinical trials for cancer and other conditions. It describes five of Geron's lead candidates in development - GRN1005, GRN163L, a combination of GRN163L with paclitaxel and bevacizumab, a combination of GRN163L with paclitaxel and carboplatin, and GRN510. Details provided on each candidate include its description, mechanism of action, and development progress.
Immuno gen, inc. – product pipeline review – 2012Rose088
The document summarizes a market research report on ImmunoGen, Inc.'s product pipeline as of 2012. It provides an overview of ImmunoGen's research areas and developmental pipeline, including current projects in various stages of development for cancer treatments. The report is compiled using data from ImmunoGen's corporate resources as well as third party sources, and includes profiles for several of ImmunoGen's lead pipeline candidates with details on their descriptions, mechanisms of action, and research progress. Links are also provided to other related product pipeline reports available.
7 tm pharma as – product pipeline review – 2012Rose088
The document summarizes a market research report on the product pipeline of 7TM Pharma A/S, a pharmaceutical company. It provides details on 7TM Pharma's current pipeline, including developmental stages of pipeline products across various therapy areas. Key pipeline molecules discussed include a drug for metabolic disorders, PAD program, TM30339, TM30510, and TM38837. The report also analyzes 7TM Pharma's research and development focus and pipeline.
The document announces the availability of a new market research report from GBI Research titled "Emerging Power Markets in South-East Asia, Middle East and Africa to 2020 - Government’s Restructuring Reforms Encouraging Private Participation will Enhance Price Competition and Efficiency". The report provides an analysis of the power markets, regulatory frameworks, and forecasts for installed capacity and generation in 7 countries in those regions through 2020. It also includes details on consumption, tables of contents, and links to other related reports.
The document summarizes a market research report from GBI Research about how cloud computing can optimize data management in pharmaceutical research and development, particularly for next-generation DNA sequencing and clinical trials data; it provides an overview of cloud computing technologies and models as well as applications in the pharmaceutical industry and competitive landscape of major cloud computing providers.
This document announces the availability of a market research report on Shire Plc's product pipeline as of 2012. The report provides an overview of Shire's research areas and pipeline of drugs in development, including those in late stage registration and clinical trials. It includes profiles for several of Shire's pipeline drugs in development, describing their purpose, mechanisms of action, and research progress. Contact information is provided to request a sample or purchase the full report.
Mundipharma international limited – product pipeline review – 2012Rose088
The document announces the availability of a market research report on Mundipharma International Limited's product pipeline as of 2012. The report provides an overview of Mundipharma's research and development focus areas and current developmental pipeline, including projects in various stages of development across therapeutic areas. It includes a snapshot of Mundipharma, descriptions of pipeline products like Bendamustine Hydrochloride and Flutiform, and contact information for requesting a sample of the full report.
This document summarizes a market research report on Actelion Ltd's product pipeline as of 2012. The report provides an overview of Actelion's research areas and pipeline of drugs in development, including those in Phase I, II, and III clinical trials. It also profiles several of Actelion's lead pipeline candidates, describing their purpose, mechanisms of action, and development progress. The full report contains additional details on Actelion's pipeline such as tables, figures, and individual drug profiles.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
The document summarizes a market research report on the Chinese markets for industrial lubricants. It examines China's economic trends, industry development, supply and demand for industrial lubricants in China. The report provides historical data from 2001 to 2011 and forecasts through 2016 and 2021. It profiles major lubricant producers in China and analyzes the industrial lubricants industry capacity, market share, technology development and major end-users. The full report is available for 50% off at $2000 and contains sections on business environment, industry assessments, and production and demand for various industrial lubricants.
This document summarizes a book about national security in Mumbai. It includes 18 chapters covering various sectors like transport, power, telecom, and others. It discusses security requirements and challenges for each sector. The book aims to assess the implications of security technologies and develop an effective system to address emerging threats. It also includes security requirements for Indian states, union territories, and some other countries.
This document summarizes a market research report on the product pipeline of Zydus Cadila Healthcare Limited. The report provides details on Zydus Cadila's research areas and developmental pipeline, including current projects in various stages of development across different therapy areas. It also lists several of Zydus Cadila's pipeline candidates, including their descriptions and development progress. Contact information is provided for requesting a sample of the full market research report.
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
The document summarizes a market research report on ZIOPHARM Oncology, Inc.'s product pipeline as of 2012. It provides an overview of ZIOPHARM's research areas and developmental pipeline, including projects in various stages of development across different therapy areas. The report also includes snapshots of key pipeline candidates such as Ad-IL-12 and DC-IL-12, along with their descriptions, mechanisms of action, and research progress. Tables of contents and figures from the full report are listed as well.
Topo target a s – product pipeline review – 2012Rose088
The document summarizes a market research report from Global Markets Direct about the product pipeline of TopoTarget A/S, a pharmaceutical company. The report provides details on TopoTarget's current developmental pipeline, including projects in clinical trials and pre-clinical research across various therapy areas. It also profiles several of TopoTarget's key pipeline drugs and combination treatment modalities in development, including their descriptions, mechanisms of action, and research progress. Contact information is provided to request a sample of the full report or for questions.
Macro genics, inc. – product pipeline review – 2012Rose088
This document summarizes a market research report about MacroGenics, Inc.'s product pipeline as of 2012. It provides an overview of MacroGenics' research areas, pipeline of products in development across various therapy areas and stages of the drug development process. It also includes brief profiles of some of MacroGenics' key pipeline products in development, such as DART for autoimmune disorders, DART mAbs, and monoclonal antibodies. The full report contains additional details on MacroGenics' pipeline like lists of tables and figures as well as related reports that can be purchased.
Ym bio sciences inc. – product pipeline review – 2012Rose088
This document summarizes a market research report on YM BioSciences Inc.'s product pipeline as of 2012. It provides an overview of YM BioSciences' business and focus on key therapeutic areas. The report also details YM's pipeline of candidates in various stages of clinical development, including Phase III, Phase II and Phase I trials, as well as combination treatment modalities. It profiles several of YM's lead pipeline candidates and outlines their mechanisms of action and development progress. Contact information is provided to request a sample of the full report or for additional related pharmaceutical reports.
The document announces the availability of a market research report on the Astrocytoma therapeutic pipeline from Global Markets Direct. The report provides an overview and details on drug candidates in development for Astrocytoma, including those from companies and universities. It covers products from discovery to registration stages and key players involved. Sample pages of the report can be requested by email.
Ipsen inc. – product pipeline review – 2012Rose088
This document summarizes a market research report on Ipsen Inc.'s product pipeline in 2012. The report provides an overview of Ipsen's research areas and pipeline of drugs in development, including those in Phase III clinical trials. It also lists Ipsen's locations and subsidiaries. The document encourages requesting a sample of the full market research report or searching for similar reports on pharmaceutical pipelines and healthcare topics through the Aarkstore website.
This document summarizes a market research report on MethylGene Inc's product pipeline as of 2012. The report provides details on MethylGene's research areas and pipeline of drug candidates at various stages of clinical trials. It describes several of MethylGene's lead drug candidates, including their mechanisms of action and development progress. Tables of contents and figures are included listing the report's contents. Contact information is provided to request a sample or purchase the full report.
This document summarizes a market research report on MerLion Pharmaceuticals Pte Ltd's product pipeline as of 2012. The report provides an overview of MerLion's research areas and developmental pipeline, including both current and discontinued/dormant projects. It describes the various stages of drug development for molecules across MerLion's portfolio in therapeutic areas such as anti-virulence, antibiotics, and anti-fungals. Tables and figures in the report provide additional details on MerLion's clinical and early-stage pipeline products. Contact information is provided for inquiries about purchasing the full report.
This document summarizes a market research report on Glenmark Pharmaceuticals Ltd's product pipeline as of 2012. The report provides details on Glenmark's research areas and pipeline of drug candidates at various stages of development, including 4 drugs in late-stage Phase III trials and several others in early-stage pre-clinical testing. Tables of contents and figures are included listing the pipeline drugs and studies. Contact information is provided to request a sample or related reports on pharmaceutical company pipelines and products.
This document summarizes a market research report from Global Markets Direct about Geron Corporation's product pipeline as of 2012. The report provides an overview of Geron's research areas and pipeline of drug candidates, including those in clinical trials for cancer and other conditions. It describes five of Geron's lead candidates in development - GRN1005, GRN163L, a combination of GRN163L with paclitaxel and bevacizumab, a combination of GRN163L with paclitaxel and carboplatin, and GRN510. Details provided on each candidate include its description, mechanism of action, and development progress.
Immuno gen, inc. – product pipeline review – 2012Rose088
The document summarizes a market research report on ImmunoGen, Inc.'s product pipeline as of 2012. It provides an overview of ImmunoGen's research areas and developmental pipeline, including current projects in various stages of development for cancer treatments. The report is compiled using data from ImmunoGen's corporate resources as well as third party sources, and includes profiles for several of ImmunoGen's lead pipeline candidates with details on their descriptions, mechanisms of action, and research progress. Links are also provided to other related product pipeline reports available.
7 tm pharma as – product pipeline review – 2012Rose088
The document summarizes a market research report on the product pipeline of 7TM Pharma A/S, a pharmaceutical company. It provides details on 7TM Pharma's current pipeline, including developmental stages of pipeline products across various therapy areas. Key pipeline molecules discussed include a drug for metabolic disorders, PAD program, TM30339, TM30510, and TM38837. The report also analyzes 7TM Pharma's research and development focus and pipeline.
The document announces the availability of a new market research report from GBI Research titled "Emerging Power Markets in South-East Asia, Middle East and Africa to 2020 - Government’s Restructuring Reforms Encouraging Private Participation will Enhance Price Competition and Efficiency". The report provides an analysis of the power markets, regulatory frameworks, and forecasts for installed capacity and generation in 7 countries in those regions through 2020. It also includes details on consumption, tables of contents, and links to other related reports.
The document summarizes a market research report from GBI Research about how cloud computing can optimize data management in pharmaceutical research and development, particularly for next-generation DNA sequencing and clinical trials data; it provides an overview of cloud computing technologies and models as well as applications in the pharmaceutical industry and competitive landscape of major cloud computing providers.
This document announces the availability of a market research report on Shire Plc's product pipeline as of 2012. The report provides an overview of Shire's research areas and pipeline of drugs in development, including those in late stage registration and clinical trials. It includes profiles for several of Shire's pipeline drugs in development, describing their purpose, mechanisms of action, and research progress. Contact information is provided to request a sample or purchase the full report.
Mundipharma international limited – product pipeline review – 2012Rose088
The document announces the availability of a market research report on Mundipharma International Limited's product pipeline as of 2012. The report provides an overview of Mundipharma's research and development focus areas and current developmental pipeline, including projects in various stages of development across therapeutic areas. It includes a snapshot of Mundipharma, descriptions of pipeline products like Bendamustine Hydrochloride and Flutiform, and contact information for requesting a sample of the full report.
This document summarizes a market research report on Actelion Ltd's product pipeline as of 2012. The report provides an overview of Actelion's research areas and pipeline of drugs in development, including those in Phase I, II, and III clinical trials. It also profiles several of Actelion's lead pipeline candidates, describing their purpose, mechanisms of action, and development progress. The full report contains additional details on Actelion's pipeline such as tables, figures, and individual drug profiles.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Debunking Nutrition Myths: Separating Fact from Fiction"AlexandraDiaz101
In a world overflowing with diet trends and conflicting nutrition advice, it’s easy to get lost in misinformation. This article cuts through the noise to debunk common nutrition myths that may be sabotaging your health goals. From the truth about carbohydrates and fats to the real effects of sugar and artificial sweeteners, we break down what science actually says. Equip yourself with knowledge to make informed decisions about your diet, and learn how to navigate the complexities of modern nutrition with confidence. Say goodbye to food confusion and hello to a healthier you!
Nutritional deficiency Disorder are problems in india.
It is very important to learn about Indian child's nutritional parameters as well the Disease related to alteration in their Nutrition.
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Addex Therapeutics – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Market Direct’s pharmaceuticals report, “Addex Therapeutics - Product
Pipeline Review - 2012” provides data on the Addex Therapeutics’s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Addex Therapeutics’s corporate website, SEC filings, investor
presentations and featured press releases, both from Addex Therapeutics and
industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Addex Therapeutics - Brief Addex Therapeutics overview including business
description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Addex Therapeutics human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Table of contents:
2. List of Tables 5
List of Figures 6
Addex Therapeutics Snapshot 7
Addex Therapeutics Overview 7
Key Information 7
Key Facts 7
Addex Therapeutics – Research and Development Overview 8
Key Therapeutic Areas 8
Addex Therapeutics – Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products – Monotherapy 12
Addex Therapeutics – Pipeline Products Glance 13
Addex Therapeutics Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Addex Therapeutics – Early Stage Pipeline Products 15
Pre-Clinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Addex Therapeutics – Drug Profiles 17
A2A PAM 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ADX48621 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
ADX68692 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
ADX71441 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
3. ADX71943 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
GABA-BR PAM 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
GIPR PAM 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
Achillion Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Addex Therapeutics – Product Pipeline Review – 2012
Adherex Technologies Inc. – Product Pipeline Review – 2012
4. Alchemia Limited – Product Pipeline Review – 2012
ALK-Abello A/S – Product Pipeline Review – 2012
Onchocerciasis (River Blindness) – Pipeline Review, H1 2012
Seborrhea – Pipeline Review, H1 2012
Cerebral Palsy – Pipeline Review, H1 2012
Hemolytic Disease In Newborns – Pipeline Review, H1 2012
Panic Disorders – Pipeline Review, H1 2012
4SC AG – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585